REPORT ID 5482

Global Retinal Vein Occlusion Therapeutics Sales Market Report 2017

Publish Date
21-Dec-17
Pages
117
Format
Electronic (PDF)

In this report, the global Retinal Vein Occlusion Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Retinal Vein Occlusion Therapeutics for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Retinal Vein Occlusion Therapeutics market competition by top manufacturers/players, with Retinal Vein Occlusion Therapeutics sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Acucela Inc
    Addmedica SAS
    Aerpio Therapeutics Inc
    Annexin Pharmaceuticals AB
    Chengdu Kanghong Pharmaceuticals Group Co Ltd
    Clearside BioMedical Inc
    Formycon AG
    Graybug Vision Inc
    Kala Pharmaceuticals Inc
    Lupin Ltd
    Mabion SA
    Novartis AG
    Ocular Therapeutix Inc
    Ohr Pharmaceutical Inc
    Regeneron Pharmaceuticals Inc
    SciFluor Life Sciences LLC
    ThromboGenics NV
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Aflibercept Biosimilar
    Aflibercept SR
    AKB-9778
    AP-01
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Research Center
    Clinic
    Hospital

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Retinal Vein Occlusion Therapeutics Sales Market Report 2017
1 Retinal Vein Occlusion Therapeutics Market Overview
    1.1 Product Overview and Scope of Retinal Vein Occlusion Therapeutics
    1.2 Classification of Retinal Vein Occlusion Therapeutics by Product Category
        1.2.1 Global Retinal Vein Occlusion Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Retinal Vein Occlusion Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Aflibercept Biosimilar
        1.2.4 Aflibercept SR
        1.2.5 AKB-9778
        1.2.6 AP-01
        1.2.7 Others
    1.3 Global Retinal Vein Occlusion Therapeutics Market by Application/End Users
        1.3.1 Global Retinal Vein Occlusion Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Research Center
        1.3.3 Clinic
        1.3.4 Hospital
    1.4 Global Retinal Vein Occlusion Therapeutics Market by Region
        1.4.1 Global Retinal Vein Occlusion Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Retinal Vein Occlusion Therapeutics Status and Prospect (2012-2022)
        1.4.3 China Retinal Vein Occlusion Therapeutics Status and Prospect (2012-2022)
        1.4.4 Europe Retinal Vein Occlusion Therapeutics Status and Prospect (2012-2022)
        1.4.5 Japan Retinal Vein Occlusion Therapeutics Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Retinal Vein Occlusion Therapeutics Status and Prospect (2012-2022)
        1.4.7 India Retinal Vein Occlusion Therapeutics Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Retinal Vein Occlusion Therapeutics (2012-2022)
        1.5.1 Global Retinal Vein Occlusion Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 Global Retinal Vein Occlusion Therapeutics Revenue and Growth Rate (2012-2022)

2 Global Retinal Vein Occlusion Therapeutics Competition by Players/Suppliers, Type and Application
     2.1 Global Retinal Vein Occlusion Therapeutics Market Competition by Players/Suppliers
        2.1.1 Global Retinal Vein Occlusion Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Retinal Vein Occlusion Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Retinal Vein Occlusion Therapeutics (Volume and Value) by Type
        2.2.1 Global Retinal Vein Occlusion Therapeutics Sales and Market Share by Type (2012-2017)
        2.2.2 Global Retinal Vein Occlusion Therapeutics Revenue and Market Share by Type (2012-2017)
    2.3 Global Retinal Vein Occlusion Therapeutics (Volume and Value) by Region
        2.3.1 Global Retinal Vein Occlusion Therapeutics Sales and Market Share by Region (2012-2017)
        2.3.2 Global Retinal Vein Occlusion Therapeutics Revenue and Market Share by Region (2012-2017)
    2.4 Global Retinal Vein Occlusion Therapeutics (Volume) by Application

3 United States Retinal Vein Occlusion Therapeutics (Volume, Value and Sales Price)
    3.1 United States Retinal Vein Occlusion Therapeutics Sales and Value (2012-2017)
        3.1.1 United States Retinal Vein Occlusion Therapeutics Sales and Growth Rate (2012-2017)
        3.1.2 United States Retinal Vein Occlusion Therapeutics Revenue and Growth Rate (2012-2017)
        3.1.3 United States Retinal Vein Occlusion Therapeutics Sales Price Trend (2012-2017)
    3.2 United States Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Players
    3.3 United States Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Type
    3.4 United States Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Application

4 China Retinal Vein Occlusion Therapeutics (Volume, Value and Sales Price)
    4.1 China Retinal Vein Occlusion Therapeutics Sales and Value (2012-2017)
        4.1.1 China Retinal Vein Occlusion Therapeutics Sales and Growth Rate (2012-2017)
        4.1.2 China Retinal Vein Occlusion Therapeutics Revenue and Growth Rate (2012-2017)
        4.1.3 China Retinal Vein Occlusion Therapeutics Sales Price Trend (2012-2017)
    4.2 China Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Players
    4.3 China Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Type
    4.4 China Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Application

5 Europe Retinal Vein Occlusion Therapeutics (Volume, Value and Sales Price)
    5.1 Europe Retinal Vein Occlusion Therapeutics Sales and Value (2012-2017)
        5.1.1 Europe Retinal Vein Occlusion Therapeutics Sales and Growth Rate (2012-2017)
        5.1.2 Europe Retinal Vein Occlusion Therapeutics Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Retinal Vein Occlusion Therapeutics Sales Price Trend (2012-2017)
    5.2 Europe Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Players
    5.3 Europe Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Type
    5.4 Europe Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Application

6 Japan Retinal Vein Occlusion Therapeutics (Volume, Value and Sales Price)
    6.1 Japan Retinal Vein Occlusion Therapeutics Sales and Value (2012-2017)
        6.1.1 Japan Retinal Vein Occlusion Therapeutics Sales and Growth Rate (2012-2017)
        6.1.2 Japan Retinal Vein Occlusion Therapeutics Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Retinal Vein Occlusion Therapeutics Sales Price Trend (2012-2017)
    6.2 Japan Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Players
    6.3 Japan Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Type
    6.4 Japan Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Application

7 Southeast Asia Retinal Vein Occlusion Therapeutics (Volume, Value and Sales Price)
    7.1 Southeast Asia Retinal Vein Occlusion Therapeutics Sales and Value (2012-2017)
        7.1.1 Southeast Asia Retinal Vein Occlusion Therapeutics Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Retinal Vein Occlusion Therapeutics Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Retinal Vein Occlusion Therapeutics Sales Price Trend (2012-2017)
    7.2 Southeast Asia Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Players
    7.3 Southeast Asia Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Type
    7.4 Southeast Asia Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Application

8 India Retinal Vein Occlusion Therapeutics (Volume, Value and Sales Price)
    8.1 India Retinal Vein Occlusion Therapeutics Sales and Value (2012-2017)
        8.1.1 India Retinal Vein Occlusion Therapeutics Sales and Growth Rate (2012-2017)
        8.1.2 India Retinal Vein Occlusion Therapeutics Revenue and Growth Rate (2012-2017)
        8.1.3 India Retinal Vein Occlusion Therapeutics Sales Price Trend (2012-2017)
    8.2 India Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Players
    8.3 India Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Type
    8.4 India Retinal Vein Occlusion Therapeutics Sales Volume and Market Share by Application

9 Global Retinal Vein Occlusion Therapeutics Players/Suppliers Profiles and Sales Data
    9.1 Acucela Inc
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Acucela Inc Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Addmedica SAS
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Addmedica SAS Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Aerpio Therapeutics Inc
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Aerpio Therapeutics Inc Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Annexin Pharmaceuticals AB
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Annexin Pharmaceuticals AB Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Chengdu Kanghong Pharmaceuticals Group Co Ltd
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Chengdu Kanghong Pharmaceuticals Group Co Ltd Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Clearside BioMedical Inc
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Clearside BioMedical Inc Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Formycon AG
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Formycon AG Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Graybug Vision Inc
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Graybug Vision Inc Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Kala Pharmaceuticals Inc
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Kala Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Lupin Ltd
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Retinal Vein Occlusion Therapeutics Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Lupin Ltd Retinal Vein Occlusion Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Mabion SA
    9.12 Novartis AG
    9.13 Ocular Therapeutix Inc
    9.14 Ohr Pharmaceutical Inc
    9.15 Regeneron Pharmaceuticals Inc
    9.16 SciFluor Life Sciences LLC
    9.17 ThromboGenics NV

10 Retinal Vein Occlusion Therapeutics Maufacturing Cost Analysis
    10.1 Retinal Vein Occlusion Therapeutics Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Retinal Vein Occlusion Therapeutics
    10.3 Manufacturing Process Analysis of Retinal Vein Occlusion Therapeutics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Retinal Vein Occlusion Therapeutics Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Retinal Vein Occlusion Therapeutics Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Retinal Vein Occlusion Therapeutics Market Forecast (2017-2022)
    14.1 Global Retinal Vein Occlusion Therapeutics Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Retinal Vein Occlusion Therapeutics Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Retinal Vein Occlusion Therapeutics Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Retinal Vein Occlusion Therapeutics Price and Trend Forecast (2017-2022)
    14.2 Global Retinal Vein Occlusion Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Retinal Vein Occlusion Therapeutics Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Retinal Vein Occlusion Therapeutics Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Retinal Vein Occlusion Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Retinal Vein Occlusion Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Retinal Vein Occlusion Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Retinal Vein Occlusion Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Sou